Emme Closes $2.5M Seed Funding Round


Emme, a San Francisco, CA-based healthcare technology company focused on women’s health, raised $2.5m in seed funding.

The round was led by Magnetic Ventures with participation from existing investors. In conjunction with the funding, Magnetic Ventures’ founding partner, Christine Aylward, joined the board, along with experienced healthcare innovator and Evidation CEO Deborah Kilpatrick.

The company intends to use the funds to launch its smart case.

Co-founded in 2017 by Amanda French and Janene Fuerch, MD, during their fellowship at Stanford Byers Center for Biodesign, Emme offers an integrated system, which reminds users to take the pill and notify at-risk users when back-up contraception is needed.

Their first product, the Emme Smart Case and app, is an integrated technology-enabled solution designed to safeguard the birth control experience and help reduce the rate of missed pills. The Emme Smart Case uses patent-pending, multi-sensor technology to track when pills are taken. The smart case syncs with the app to send persistent customized reminders until the dose is taken and provides contraceptive guidance when needed. The app also offers users a comprehensive view of their health by supporting cycle, mood, and side effect tracking.



Join the discussion